Literature DB >> 35673440

High levels of FBS and HbA1c and their association with diabetic retinopathy: a study in the north of Iran.

Seyed Ahmad Rasoulinejad1, Neda Meftah1, Mohammad Saeed Maniati2, Mahmood Maniati3.   

Abstract

Background: Diabetic retinopathy, which is a common complication of diabetes, is one of the most common reasons of blindness in adults. There are several potential risk factors for diabetic retinopathy such as hypertension (HTN), hyperlipidemia (HLP), high fasting blood sugar (FBS), and high Hemoglobin A1c (HbA1c). Yet, ethnicity is another factor which may contribute to diabetic retinopathy regardless of the potential risk factors mentioned. The aim of this study, therefore, is to find the risk factors associated with diabetic retinopathy in the north of Iran.
Methods: This was a retrospective cohort study including a total of 1,125 patients divided into three groups as follows: (i) patients with no diabetic retinopathy (NDR group; n = 398); (ii) patients with non-proliferative diabetic retinopathy (non-PDR group; n = 408); (iii) patients with proliferative diabetic retinopathy (PDR group; n = 319). The laboratory data were collected from patients for analysis.
Results: Diabetic patients with retinopathy had significantly higher levels of FBS compared with those without retinopathy (p = 0.001). Patients with PDR or non-PDR had higher levels of HbA1c compared with patients without retinopathy (p = 0.001). In contrast, no association was observed between HTN or HLP and diabetic retinopathy. On the other hand, duration of diabetes was another important factor affecting diabetic retinopathy. Conclusions: Higher levels of FBS and HbA1c were observed in patients with diabetic retinopathy. Monitoring and controlling of FBS and HbA1c of diabetic patients could prevent the occurrence of diabetic retinopathy. © Springer Nature Switzerland AG 2022.

Entities:  

Keywords:  Diabetes; Diabetic retinopathy; PDR; Proliferative diabetic retinopathy; Risk factors

Year:  2022        PMID: 35673440      PMCID: PMC9167345          DOI: 10.1007/s40200-022-00986-5

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  20 in total

1.  Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.

Authors:  Frank M Sacks; Michel P Hermans; Paola Fioretto; Paul Valensi; Timothy Davis; Edward Horton; Christoph Wanner; Khalid Al-Rubeaan; Ronnie Aronson; Isabella Barzon; Louise Bishop; Enzo Bonora; Pongamorn Bunnag; Lee-Ming Chuang; Chaicharn Deerochanawong; Ronald Goldenberg; Benjamin Harshfield; Cristina Hernández; Susan Herzlinger-Botein; Hiroshi Itoh; Weiping Jia; Yi-Der Jiang; Takashi Kadowaki; Nancy Laranjo; Lawrence Leiter; Takashi Miwa; Masato Odawara; Ken Ohashi; Atsushi Ohno; Changyu Pan; Jiemin Pan; Juan Pedro-Botet; Zeljko Reiner; Carlo Maria Rotella; Rafael Simo; Masami Tanaka; Eugenia Tedeschi-Reiner; David Twum-Barima; Giacomo Zoppini; Vincent J Carey
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

Review 2.  Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review.

Authors:  Daniel Shu Wei Ting; Gemmy Chui Ming Cheung; Tien Yin Wong
Journal:  Clin Exp Ophthalmol       Date:  2016-02-17       Impact factor: 4.207

Review 3.  Associations between diabetic retinopathy and systemic risk factors.

Authors:  N Wat; R Lm Wong; I Yh Wong
Journal:  Hong Kong Med J       Date:  2016-10-24       Impact factor: 2.227

4.  Early Assessment of the Risk Factors for Diabetic Retinopathy Can Reduce the Risk of Peripheral Arterial and Cardiovascular Diseases in Type 2 Diabetes.

Authors:  Juan Tang; Tao Li; Pinhong Li; Yuefei Ma; Momo Liu; Qiaoyun Shan; Fengqi Guo; Ting Zhou; Qianping Wei
Journal:  Ophthalmic Res       Date:  2017-09-21       Impact factor: 2.892

Review 5.  The pathology associated with diabetic retinopathy.

Authors:  Judith Lechner; Olivia E O'Leary; Alan W Stitt
Journal:  Vision Res       Date:  2017-04-29       Impact factor: 1.886

6.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

Review 7.  Biomarkers in Diabetic Retinopathy.

Authors:  Alicia J Jenkins; Mugdha V Joglekar; Anandwardhan A Hardikar; Anthony C Keech; David N O'Neal; Andrzej S Januszewski
Journal:  Rev Diabet Stud       Date:  2015-08-10

8.  Influence of Age at Diagnosis and Time-Dependent Risk Factors on the Development of Diabetic Retinopathy in Patients with Type 1 Diabetes.

Authors:  Luis Forga; María José Goñi; Berta Ibáñez; Koldo Cambra; Marta García-Mouriz; Ana Iriarte
Journal:  J Diabetes Res       Date:  2016-04-26       Impact factor: 4.011

9.  Retinopathy progression and the risk of end-stage kidney disease: results from a longitudinal Japanese cohort of 232 patients with type 2 diabetes and biopsy-proven diabetic kidney disease.

Authors:  Masayuki Yamanouchi; Mikiro Mori; Junichi Hoshino; Keiichi Kinowaki; Takeshi Fujii; Kenichi Ohashi; Kengo Furuichi; Takashi Wada; Yoshifumi Ubara
Journal:  BMJ Open Diabetes Res Care       Date:  2019-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.